Opiant Pharmaceuticals Inc

NASDAQ:OPNT   3:59:54 PM EDT
29.55
+2.80 (+10.47%)
Positive Earnings Pre-Announcement

Opiant Pharmaceuticals Announces Third Quarter 2021 Financial Results And Provides Corporate Update

Published: 11/11/2021 22:13 GMT
Opiant Pharmaceuticals Inc (OPNT) - Opiant Pharmaceuticals Announces Third Quarter 2021 Financial Results and Provides Corporate Update.
Q3 Revenue Rose 79 Percent to $16.3 Million.
Raises Full-year 2021 Revenue and Cash Guidance.
Q3 Earnings per Share $0.56.
Opiant Pharmaceuticals - Expects Full-year 2021 Royalty Revenue From Sale of Narcan Nasal Spray of About $38 Million.
Opiant Pharmaceuticals - Now Expects to End 2021 With Cash, Cash Equivalents and Marketable Securities in Range of About $50 Million to $52 Million.
Revenue is expected to be $13.6 Million
Adjusted EPS is expected to be $0.01

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be $0.00

More details on our Analysts Page.